Literature DB >> 17539465

Cosmetic neurology and cosmetic surgery: parallels, predictions, and challenges.

Anjan Chatterjee1.   

Abstract

Mesh:

Year:  2007        PMID: 17539465     DOI: 10.1017/s0963180107070156

Source DB:  PubMed          Journal:  Camb Q Healthc Ethics        ISSN: 0963-1801            Impact factor:   1.284


× No keyword cloud information.
  7 in total

1.  Cognitive and Performance Enhancing Medication Use to Improve Performance in Poker.

Authors:  Joshua Caballero; Raymond L Ownby; Jose A Rey; Kevin A Clauson
Journal:  J Gambl Stud       Date:  2016-09

Review 2.  Rethinking the thinking cap: ethics of neural enhancement using noninvasive brain stimulation.

Authors:  Roy Hamilton; Samuel Messing; Anjan Chatterjee
Journal:  Neurology       Date:  2011-01-11       Impact factor: 9.910

Review 3.  The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders.

Authors:  Maddalena Mereu; Antonello Bonci; Amy Hauck Newman; Gianluigi Tanda
Journal:  Psychopharmacology (Berl)       Date:  2013-08-10       Impact factor: 4.530

4.  Physician attitudes towards pharmacological cognitive enhancement: safety concerns are paramount.

Authors:  Opeyemi C Banjo; Roland Nadler; Peter B Reiner
Journal:  PLoS One       Date:  2010-12-14       Impact factor: 3.240

5.  Evaluating the drivers of and obstacles to the willingness to use cognitive enhancement drugs: the influence of drug characteristics, social environment, and personal characteristics.

Authors:  Sebastian Sattler; Guido Mehlkop; Peter Graeff; Carsten Sauer
Journal:  Subst Abuse Treat Prev Policy       Date:  2014-02-01

6.  Generating genius: how an Alzheimer's drug became considered a 'cognitive enhancer' for healthy individuals.

Authors:  Lucie Wade; Cynthia Forlini; Eric Racine
Journal:  BMC Med Ethics       Date:  2014-05-12       Impact factor: 2.652

7.  The rationale for consuming cognitive enhancement drugs in university students and teachers.

Authors:  Sebastian Sattler; Carsten Sauer; Guido Mehlkop; Peter Graeff
Journal:  PLoS One       Date:  2013-07-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.